Latest
Alvotech’s share price jumps after FDA approval for new Simlandi manufacturing process
The U.S. FDA has approved a new manufacturing method for Simlandi, Alvotech's biosimilar to Humira, allowing the company to scale up production. The news sent Alvotech’s share price up about 7% Tuesday.